The Erythropoietin (EPO) Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Erythropoietin (EPO) Market:
https://www.thebusinessresearchcompany.com/report/erythropoietins-global-market-report
According to The Business Research Company’s Erythropoietin (EPO) Global Market Report 2024, The erythropoietin (epo) market size has grown rapidly in recent years. It will grow from $17.29 billion in 2023 to $19.25 billion in 2024 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to patient education and awareness, pharmaceutical industry consolidation, healthcare reimbursement policies, market expansion and demand growth, patent expiration and biosimilar entry.
The erythropoietin (epo) market size is expected to see rapid growth in the next few years. It will grow to $30.92 billion in 2028 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to market competition and biosimilar impact, disease prevalence projections, healthcare policy and reimbursement changes, emerging markets growth, clinical trials and research focus. Major trends in the forecast period include supply chain management, global expansion and emerging markets, patient education and awareness, reimbursement policies, market consolidation and mergers.
The rising incidence of chronic kidney diseases is anticipated to propel the demand for the erythropoietin market over the coming years. The growing cases of chronic kidney disease require erythropoietin administration, which is used to make red blood cells to improve immunity. For instance, in March 2021, according to the Centers for Disease Control and Prevention’s report published on chronic kidney disease in the United States, 15% of the adults in the USA, or 37 million people, were estimated to have chronic kidney disease (CKD). People aged 65 or older are more likely to have CKD (38%), followed by those aged 45-64 (13%), and those aged 18-44 (7%).Chronic kidney diseases lead to an anaemic condition, which in turn increases the demand for erythropoietin to curb the condition, thereby driving the market revenues.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=3436&type=smp
The erythropoietin (epo) market covered in this report is segmented –
1) By Product: Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Other Products
2) By Drug Class: Biologis, Biosimilar
3) By Application: Cancer, Hematology, Renal diseases, Neurology, Other Applications
Major companies operating in the erythropoietin market are developing innovative products such as Varenzin-CA1 to mark their position in the market. Varenzin-CA1 (molidustat oral suspension) is a conditionally approved drug by the FDA for the control of nonregenerative anemia associated with chronic kidney disease (CKD) in cats. For instance, in May 2023, Elanco, a US-based pharmaceutical company received FDA approval for Varenzin-CA1. It is developed exclusively for cats and features a mode of action that induces the genetic transcription of erythropoietin (EPO), increasing both EPO and red blood cell production in a cat’s body. Varenzin-CA1 is a breakthrough innovation that meets at-home convenience and sets a new standard of care for cats suffering from nonregenerative anemia due to CKD.
The erythropoietin (epo) market report table of contents includes:
1. Executive Summary
2. Erythropoietin (EPO) Market Characteristics
3. Erythropoietin (EPO) Market Trends And Strategies
4. Erythropoietin (EPO) Market – Macro Economic Scenario
5. Global Erythropoietin (EPO) Market Size and Growth
.
.
.
26. South America Erythropoietin (EPO) Market
27. Brazil Erythropoietin (EPO) Market
28. Middle East Erythropoietin (EPO) Market
29. Africa Erythropoietin (EPO) Market
30. Erythropoietin (EPO) Market Competitive Landscape And Company Profiles
Top Major Players:
- BASF SE
- Hoffmann-La Roche AG
- Merck Sharp & Dohme LLC
- Sanofi SA
- Thermo Fisher Scientific Inc
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
